White House Issues New High-Risk Life Sciences Policy Focused on AI Risk Monitoring
The White House has introduced a new policy framework addressing high-risk life sciences, with specific provisions calling for systematic monitoring of AI-related risks in the sector. The policy represents an expansion of federal oversight efforts focused on artificial intelligence applications in sensitive domains such as healthcare, biotechnology, and biomedical research.